278 related articles for article (PubMed ID: 10471507)
1. Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia.
Hurvitz JR; Suwairi WM; Van Hul W; El-Shanti H; Superti-Furga A; Roudier J; Holderbaum D; Pauli RM; Herd JK; Van Hul EV; Rezai-Delui H; Legius E; Le Merrer M; Al-Alami J; Bahabri SA; Warman ML
Nat Genet; 1999 Sep; 23(1):94-8. PubMed ID: 10471507
[TBL] [Abstract][Full Text] [Related]
2. WISP3, the gene responsible for the human skeletal disease progressive pseudorheumatoid dysplasia, is not essential for skeletal function in mice.
Kutz WE; Gong Y; Warman ML
Mol Cell Biol; 2005 Jan; 25(1):414-21. PubMed ID: 15601861
[TBL] [Abstract][Full Text] [Related]
3. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
Yu C; Le AT; Yeger H; Perbal B; Alman BA
J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
[TBL] [Abstract][Full Text] [Related]
4. [Clinical diagnosis and WISP3 gene mutation analysis for progressive pseudorheumatoid dysplasia].
Ye J; Zhang HW; Wang T; Cao LF; Qiu WJ; Han LS; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):194-8. PubMed ID: 20426955
[TBL] [Abstract][Full Text] [Related]
5. The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling.
Nakamura Y; Weidinger G; Liang JO; Aquilina-Beck A; Tamai K; Moon RT; Warman ML
J Clin Invest; 2007 Oct; 117(10):3075-86. PubMed ID: 17823661
[TBL] [Abstract][Full Text] [Related]
6. Cellular and molecular responses in progressive pseudorheumatoid dysplasia articular cartilage associated with compound heterozygous WISP3 gene mutation.
Zhou HD; Bu YH; Peng YQ; Xie H; Wang M; Yuan LQ; Jiang Y; Li D; Wei QY; He YL; Xiao T; Ni JD; Liao EY
J Mol Med (Berl); 2007 Sep; 85(9):985-96. PubMed ID: 17483925
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel mutations in WISP3 gene in two unrelated Chinese families with progressive pseudorheumatoid dysplasia.
Yue H; Zhang ZL; He JW
Bone; 2009 Apr; 44(4):547-54. PubMed ID: 19064006
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells.
Hashimoto Y; Shindo-Okada N; Tani M; Nagamachi Y; Takeuchi K; Shiroishi T; Toma H; Yokota J
J Exp Med; 1998 Feb; 187(3):289-96. PubMed ID: 9449709
[TBL] [Abstract][Full Text] [Related]
9. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family.
Brigstock DR
Endocr Rev; 1999 Apr; 20(2):189-206. PubMed ID: 10204117
[No Abstract] [Full Text] [Related]
10. Identification of a mutation in the WISP3 gene in three unrelated families with progressive pseudorheumatoid dysplasia.
Yu Y; Hu M; Xing X; Li F; Song Y; Luo Y; Ma H
Mol Med Rep; 2015 Jul; 12(1):419-25. PubMed ID: 25738435
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
[TBL] [Abstract][Full Text] [Related]
12. NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues.
Perbal B
Mol Pathol; 2001 Apr; 54(2):57-79. PubMed ID: 11322167
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the WISP3 gene in Indian families with progressive pseudorheumatoid dysplasia.
Dalal A; Bhavani G SL; Togarrati PP; Bierhals T; Nandineni MR; Danda S; Danda D; Shah H; Vijayan S; Gowrishankar K; Phadke SR; Bidchol AM; Rao AP; Nampoothiri S; Kutsche K; Girisha KM
Am J Med Genet A; 2012 Nov; 158A(11):2820-8. PubMed ID: 22987568
[TBL] [Abstract][Full Text] [Related]
14. Molecular study of WISP3 in nine families originating from the Middle-East and presenting with progressive pseudorheumatoid dysplasia: identification of two novel mutations, and description of a founder effect.
Delague V; Chouery E; Corbani S; Ghanem I; Aamar S; Fischer J; Levy-Lahad E; Urtizberea JA; Mégarbané A
Am J Med Genet A; 2005 Oct; 138A(2):118-26. PubMed ID: 16152649
[TBL] [Abstract][Full Text] [Related]
15. A homozygous recurring mutation in WISP3 causing progressive pseudorheumatoid arthropathy.
Temiz F; Ozbek MN; Kotan D; Sangun O; Mungan NO; Yuksel B; Topaloglu AK
J Pediatr Endocrinol Metab; 2011; 24(1-2):105-8. PubMed ID: 21528827
[TBL] [Abstract][Full Text] [Related]
16. The CCN family: a new stimulus package.
Brigstock DR
J Endocrinol; 2003 Aug; 178(2):169-75. PubMed ID: 12904165
[TBL] [Abstract][Full Text] [Related]
17. Novel and recurrent mutations of WISP3 in two Chinese families with progressive pseudorheumatoid dysplasia.
Sun J; Xia W; He S; Zhao Z; Nie M; Li M; Jiang Y; Xing X; Wang O; Meng X; Zhou X
PLoS One; 2012; 7(6):e38643. PubMed ID: 22685593
[TBL] [Abstract][Full Text] [Related]
18. Mutant WISP3 triggers the phenotype shift of articular chondrocytes by promoting sensitivity to IGF-1 hypothesis of spondyloepiphyseal dysplasia tarda with progressive arthropathy (SEDT-PA).
Yang Y; Liao E
Med Hypotheses; 2007; 68(6):1406-10. PubMed ID: 17363178
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic challenge of progressive pseudorheumatoid dysplasia (PPRD): a review of clinical features, radiographic features, and WISP3 mutations in 63 affected individuals.
Garcia Segarra N; Mittaz L; Campos-Xavier AB; Bartels CF; Tuysuz B; Alanay Y; Cimaz R; Cormier-Daire V; Di Rocco M; Duba HC; Elcioglu NH; Forzano F; Hospach T; Kilic E; Kuemmerle-Deschner JB; Mortier G; Mrusek S; Nampoothiri S; Obersztyn E; Pauli RM; Selicorni A; Tenconi R; Unger S; Utine GE; Wright M; Zabel B; Warman ML; Superti-Furga A; Bonafé L
Am J Med Genet C Semin Med Genet; 2012 Aug; 160C(3):217-29. PubMed ID: 22791401
[TBL] [Abstract][Full Text] [Related]
20. Early severe scoliosis in a patient with atypical progressive pseudorheumatoid dysplasia (PPD): Identification of two WISP3 mutations, one previously unreported.
Montané LS; Marín OR; Rivera-Pedroza CI; Vallespín E; Del Pozo Á; Heath KE
Am J Med Genet A; 2016 Jun; 170(6):1595-9. PubMed ID: 26991965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
